AL 47-LEA CONGRES AL SOCIETĂȚII ROMÂNE DE ANESTEZIE ȘI TERAPIE INTENSIVĂ

AL 15-LEA CONGRES ROMÂNO-FRANCEZ DE ANESTEZIE ȘI TERAPIE INTENSIVĂ
AL 13-LEA SIMPOZION ROMÂNO-ISRAELIAN DE ACTUALITĂȚI ÎN ANESTEZIE ȘI TERAPIE INTENSIVĂ
AL 20-LEA CONGRES AL ASISTENȚILOR DE ANESTEZIE ȘI TERAPIE INTENSIVĂ
AL 8-LEA SIMPOZION "ROMÂNIA DODOLOAȚĂ" AL SOCIETĂȚILOR DE ANESTEZIE ȘI TERAPIE INTENSIVĂ DIN ROMÂNIA ȘI MOLDOVA


15 - 19 SEPTEMBRIE 2021
Eveniment virtual

Începând cu 04 septembrie (înscriere târzie)

Ecaterina SCĂRLĂTESCU 


Ecaterina Scărlătescu, MD graduated from the University of Medicine and Pharmacy Carol Davila of Bucharest in 2005 and trained in Anaesthesia and Intensive Care medicine at Fundeni Clinical Institute, Bucharest, Romania. After the residency, she continued to work in the Department of Anaesthesiology and Intensive Care III at Fundeni Clinical Institute where she is appointed as Consultant.

She is involved in clinical work (visceral and thoracic surgery, liver transplantation, care of the medical and surgical intensive care patients- both adults and paediatric patients), but also in research and training activities. She received a RTW Fellowship from the International Society on Hemostasis and Thrombosis in 2017, and trained for three months at Maastricht University Medical Center in Maastricht, the Netherlands on the topics of the anticoagulant management in patients on extracorporeal life support and the use of thrombin generation tests.

In 2018 she completed her PhD with the thesis “The complex assessment of coagulation disturbances in early sepsis and their prognostic significance”.  She is lecturer and co-course director for Danube University Krems (DUK) Seminars on Severe Bleeding Management - Patient Blood Management and she serves as an associate editor for BMC Anaesthesiology and as reviewer for different journals on topics related to Critical Care medicine, Anaesthesia and coagulation.

Major research interests and current research projects include: the study of sepsis associated coagulopathy and sepsis induced DIC, the  assessment of hemostasis in acute liver failure and end stage liver diseases, the assessment of coagulopathy in cirrhotic patients with sepsis and septic shock, bleeding management in liver transplantation, antithrombotic therapy monitoring in liver cirrhosis patients, extracorporeal blood purification therapies for supportive treatment of acute liver failure patients and as bridging to liver transplantation, the diagnostic and clinical implications of cirrhotic cardiomyopathy and post-reperfusion syndrome during liver transplantation.